A GLP-1 starts acting with the first dose, but nobody is on the dose that produced the trial results for months, and that is by design. When people ask how long Ozempic, Wegovy or Zepbound takes to work, there are three clocks running at once: the label's dose calendar, the time it takes the drug to reach steady levels in your blood, and the weeks at which the trials actually measured results. All three are published. This guide puts them side by side and promises nothing: the only weight figures here are trial averages, each with its week number.
Clock 1: the label's dose calendar
Every one of these drugs starts at a low dose and climbs, because gut side effects are worst when the dose rises fast. The labels set the pace.
| Drug | Start | Steps | Earliest week at the main dose |
|---|---|---|---|
| Wegovy (injection) | 0.25 mg weekly | 0.5, 1, 1.7, then 2.4 mg, every 4 weeks | Week 17 for 2.4 mg |
| Zepbound | 2.5 mg weekly for 4 weeks | 2.5 mg steps, at least 4 weeks each | Week 5 for 5 mg; week 13 for 10 mg; week 21 for 15 mg |
| Ozempic (type 2 diabetes) | 0.25 mg weekly for 4 weeks | 0.5 mg, then 1 or 2 mg if needed, at least 4 weeks apart | Week 5 for 0.5 mg |
Wegovy's label starts at "0.25 mg administered subcutaneously once weekly" and lists 1.7 mg or 2.4 mg as the maintenance dose for weight loss, with 2.4 mg recommended; its escalation table covers weeks 1 to 16, with maintenance from week 17.1 Zepbound starts at "2.5 mg ... once weekly for 4 weeks" and rises "in 2.5 mg increments, after at least 4 weeks on the current dose" to a maintenance dose of 5, 10 or 15 mg.2 Ozempic starts at "0.25 mg ... once weekly for 4 weeks", then 0.5 mg, with 1 mg or 2 mg if more glucose control is needed.3
Two newer versions run on different clocks. The Wegovy pill starts at "1.5 mg taken orally once daily", and its label table steps up to 4 mg on day 31, 9 mg on day 61 and the 25 mg maintenance dose from day 91, so about three months to full dose.10 And Wegovy now has a higher injection: for people who "tolerate the 2.4 mg dosage for at least 4 weeks", the dose "may be increased to a maximum dosage of 7.2 mg".10 That adds at least another month on top of Wegovy's 16-week climb, and the Wegovy 7.2 mg guide covers what it changes.
"At least" is doing real work in those sentences. The labels set the fastest pace, not a deadline. If side effects are hard, prescribers often hold a dose for longer; that stretches the calendar, and it is normal.
Clock 2: how fast the drug builds up
These are once-weekly drugs with long half-lives, so each new dose takes a few weeks to reach a stable level in the blood. The Ozempic label says semaglutide's "steady-state exposure is achieved following 4 to 5 weeks of once-weekly administration".4 The Zepbound label says tirzepatide's "steady-state plasma tirzepatide concentrations were achieved following 4 weeks of once weekly administration".5
That is why the dose steps are 4 weeks apart: each step gets roughly a month to settle before the next. It also works in reverse. Semaglutide's half-life is about a week, so it "will be present in the circulation for about 5 weeks after the last dose";4 tirzepatide's half-life is about 5 to 6 days.5 Effects do not switch off the day you stop.
When side effects ease
The flip side of the slow climb is that side effects cluster at the start of each step. The Zepbound label puts it plainly: "the majority of nausea, vomiting, and/or diarrhea events occurred during dose escalation and decreased over time".11 In practice, the first weeks after each dose increase are the hardest, and the weeks after you settle on a maintenance dose are usually easier. The GLP-1 diet guide covers the eating habits that help during those weeks.
Clock 3: where the trials measured results
Trials report averages at fixed weeks. These are the published timepoints, in order:
| When | Drug and trial | Average weight change |
|---|---|---|
| Week 20 | Wegovy, STEP 4 run-in (16 weeks of escalation, 4 at 2.4 mg) | -10.6% |
| Week 36 | Zepbound, SURMOUNT-4 lead-in | -20.9% |
| Week 68 | Wegovy 2.4 mg, STEP 1 | -14.9% (placebo -2.4%) |
| Week 72 | Zepbound, SURMOUNT-1 | -15.0% (5 mg), -19.5% (10 mg), -20.9% (15 mg); placebo -3.1% |
Sources: STEP 4,6 SURMOUNT-4,8 STEP 17 and SURMOUNT-1.9 Read the early rows with care. The week 20 and week 36 figures come from people who completed a run-in and, in STEP 4, "who reached the 2.4-mg/wk semaglutide maintenance dose".6 People who stopped early are not in those averages, so they flatter the drug a little. The week 68 and 72 figures are from full randomized trials against placebo and are the fairer comparison.
What the timepoints show together: most of the weight change happens over months, not weeks, and it is still accumulating well after the dose stops rising. A quiet first month on the starting dose is what the trial curves predict, not a sign the drug has failed.
Ozempic for type 2 diabetes: a different clock
Ozempic's approved use is glucose control in type 2 diabetes, and its trials measured A1C. In the label's monotherapy trial, "OZEMPIC 0.5 mg and 1 mg once weekly for 30 weeks resulted in a statistically significant reduction in HbA1c compared with placebo": A1C fell 1.4 points on 0.5 mg and 1.6 on 1 mg, against 0.1 on placebo.4 The Ozempic for weight loss guide covers what its label says about weight.
Missed doses reset part of the clock
Because the dose calendar exists to let your gut adjust, long gaps undo some of it. The labels handle this differently:
- Zepbound: take a missed dose "as soon as possible within 4 days (96 hours)"; if more than 4 days have passed, skip it and take the next one on your usual day.11
- Wegovy injection: "if 2 or more consecutive doses of WEGOVY injection are missed, reinitiate dosage escalation at a lower dosage to reduce the risk of gastrointestinal adverse reactions".10 Two missed weeks can mean climbing part of the ladder again.
How far back to restart is your prescriber's call. The practical point for timing: a supply gap, a lapsed insurance approval or a pharmacy delay costs more than the missed weeks themselves.
What changes your own timeline
- How fast your dose rises. Holding a dose for side effects adds weeks before you reach the dose the trials tested.2
- Which dose you stay on. SURMOUNT-1 shows the dose matters: 15.0% on 5 mg against 20.9% on 15 mg at week 72.9
- Diet and activity. Every trial here paired the drug with diet and activity counselling; the GLP-1 diet guide covers what four medical societies recommend.
- Staying on it. Gaps restart the climb; the stopping guide covers what the trials show when treatment ends.
The cost of the waiting months
The escalation months are cheaper at some sellers and the same price at others, because some programs charge the same at every dose. That difference is real money over the 4 to 5 months it takes to reach a full dose. The board ranks every partner program we track by what you pay each month, all in; the titration cost tool prices each month of the label's schedule.
